Youre gonna end up with ozempic foot or ozempic face
Because IGF-1 is a central mediator of GHs effects, even minor deviations can disproportionately alter metabolism, growth, and repair processes
In addition, a large number of clinical studies have shown that GLP-/GIP dual agonists can reduce LFC, VAT, and body weight, and have an improvement effect on both NAFLD and NASH [131,132]
10.1016/j.bbagen.2012.09.008 Biochim Biophys Acta
rabbit polyclonal antibodies against human ADH1, catalase, NRF2, CYP2E1 (all from Santa Cruz, Dallas, Texas), ALDH1B1 61 , and ALDH2 62
Peptide therapy clinics specialize in this area